Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Lu AF35700 Clinical vs Commercial Tablets
NCT03394482Phase 1Completed
- Sponsor
- Lundbeck
- Start
- Jan 2018
- Primary completion
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lu af35700 in schizophrenia (6 arms), sponsored by Lundbeck. Primary endpoints: Area Under the Curve from time zero to 72 hours and Maximum Plasma Concentration. Started Jan 2018; status: completed.
02
Drugs
lu af35700
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT03394482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03394482.